Accordingly, combined MYC/NMYC and NF-κB inhibition using 10 μM KJ-Pyr-9 with dexamethasone and/or PDTC did not result in synergistic reductions in survival of NSCLC-derived LCSC-like cells. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.